Company: SRPT
Filing Date: 2025-12-11
Form Type: 8-K
Source: 0001193125-25-315032
Chunk: 2

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-12-11
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01      Financial Statements and Exhibits  

(d) Exhibits

  Exhibit      Description                                                                                                                              
                                                                                                                                                        
   Number                                                                                                                                               
     99.1      Press Release dated December 11, 2025                                                                                                    
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      The cover page from this Current Report on Form 8-K of Sarepta Therapeutics, Inc., formatted in Inline XBRL and included as Exhibit 101  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                        Sarepta Therapeutics, Inc.             
  Date: December 11, 2025      By:      /s/ Ian Estepan                        
                                        Ian Estepan